Mankind Pharma Ltd

NSE: MANKIND · BSE: 543904 · Pharmaceuticals & Biotechnology · 50 announcements

Share price: ₹2,500.00
Market cap: ₹1,03,261 Cr
Revenue (annual): ₹14,278 Cr
Net profit (annual): ₹1,913 Cr
P/E (TTM): 50.5×Sector 47.3×
Promoter holding: 72.63%-0.03% QoQ
FII holding: 9.45%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Merger & Restructuring 4 Other Announcement 2 Management Change 2 Employee Stock Options 2 Annual General Meeting 2 Share Pledge 1 Partnership 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

17 Sep 2026 19:07 IST NSE

Annual General Meeting

Mankind Pharma Annual General Meeting

Mankind Pharma announced the successful passing of a special resolution to appoint Mr. Anish Vanraj Bafna as a Non-Executive Independent Director. The Postal Ballot concluded with the required majority.

Read the filing ↗

18 Aug 2026 15:48 IST BSE

Annual General Meeting

Mankind Pharma Annual General Meeting

Mankind Pharma Limited has issued a Postal Ballot Notice to seek shareholder approval for the appointment of Mr. Anish Vanraj Bafna as a Non-Executive Independent Director.

Read the filing ↗